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Abstract
Pooled CRISPR libraries are widely used in high-throughput screening to study various bio-
logical processes. Various pooled CRISPR libraries have been shared for CRISPR screens
and useful tools have been developed to construct researcher’s own libraries, however,
many researchers are struggling to create their own pooled CRISPR libraries: it is a time-
consuming, labor-intensive, and expensive process. In this study, we develop a simple
method to customize conventional pooled CRISPR libraries using the CRISPR/Cas9 sys-
tem. We show that conventional pooled CRISPR libraries can be modified by eliminating
gRNAs that target positive genes, enabling the identification of unknown target genes in
CRISPR screening. CRISPR/Cas9 system can be applied as a precise tool for customizing
conventional pooled CRISPR libraries and will broaden the scope of high-throughput
screening technology.
Introduction
Various pooled libraries, such as shRNA and cDNA libraries, have been developed for high-
throughput functional studies[1]. Currently, the Clustered regularly interspaced short palin-
dromic repeat (CRISPR)-Cas9 technology for genome engineering is evolving rapidly[2] and
CRISPR-based pooled libraries are widely used in high-throughput functional studies to
understand various biological processes[3]. The pooled CRISPR library, comprising guide
RNAs (gRNAs) targeting individual genes in the genome, is used with Cas9 or Cas9 variants in
loss-of-function or gain-of-function studies[4–9]. Although several groups provide pooled
CRISPR libraries via the non-profit company, Addgene, researchers still require customized
libraries for their investigations[10]. Since the generation of new libraries for researcher’s own
study is a time-consuming, labor-intensive, and expensive process, we developed an innovative
method for customizing conventional pooled CRISPR libraries. We show that the sequence-
specific depletion of desired gRNAs from conventional CRISPR libraries is possible and these
gRNA-depleted libraries can be used for high-throughput screening. Furthermore, we demon-
strate that 81 gRNAs, targeting 27 kinase genes related to the targets of FDA-approved drugs
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can be simultaneously eliminated from pooled CRISPR libraries. Based on our results, Cas9
ribonucleoproteins (RNPs) can be employed to customize conventional pooled CRISPR librar-
ies for use in various biological screening procedures.
Materials and methods
Purification of Cas9 proteins and in vitro transcription of rc-gRNAs
Recombinant Cas9 proteins were expressed in Escherichia coli and purified by affinity chroma-
tography using Ni-NTA agarose beads. LB broth (400 mL) containing 50 μg/mL kanamycin
was inoculated with 4 mL of overnight-cultured BL21 (DE3) cells containing pET-His6-spCas9
plasmid DNA. When optical density at 600 nm (OD600) reached 0.6, Cas9 protein expression
was induced by treating the cells with 0.2 mM IPTG for 16 h at 18˚C. The cell pellet was har-
vested by centrifugation at 6,000 × g for 20 min and stored at −80˚C until purification. For
protein purification, the cell pellet was thawed on ice for 15 min and lysed with 4 mL of lysis
buffer (50 mM NaH2PO4, 300 mM NaCl and 10 mM imidazole, pH 8.0) supplemented with 1
mM PMSF, 1 mM DTT, 1 mg/mL lysozyme and 600 units of Benzonase1 Nuclease. The cell
lysate was cleared by centrifugation at 10,000 × g for 30 min and applied to Ni-NTA agarose
beads according to the manufacturer’s instructions and an imidazole gradient (20 mM wash
buffer and 250 mM elution buffer) were used to wash and elute the proteins. The eluent was
buffer-exchanged with Cas9 storage buffer (20 mM HEPES, 150 mM KCl, 1 mM DTT and
40% glycerol, pH 7.5) using a PD-10 desalting column and concentrated using Amicon1
Ultra-4 100K according to the manufacturer’s instructions. The purified Cas9 proteins were
separated by SDS-PAGE. gRNAs were synthesized in vitro using T7 RNA polymerase. Tem-
plates for gRNA synthesis were synthesised by annealing and extending two complementary
oligonucleotides, which are listed in Table B in S1 File. For a 100-μL in vitro transcription reac-
tion, T7 RNA polymerase buffer containing 1.5 μg of PCR products, each NTP at 4 mM, 14
mM MgCl2 and 100 units of RNase inhibitor was incubated with 500 units of T7 RNA poly-
merase for 3 h at 37˚C. Subsequently, the reaction mixture was treated with DNase I for 30
min at 37˚C and the in vitro-transcribed gRNAs were purified using an miRNeasy kit.
Cas9 RNPs treatment for gRNA depletion from pooled CRISPR libraries
For generating the gRNA-depleted library, 20 μg of pooled CRISPR library plasmids DNA
(human GeCKO v1 and v2 lentiviral sgRNA libraries, Addgene #1000000049) was incubated
with NEBuffer 3.1 containing 1× Cas9 RNPs and a complex of 10 μg of Cas9 proteins and
7.5 μg of rc-gRNAs for 8 h at 37˚C. Subsequently, the mixture was treated with RNase A for 30
min at 37˚C and the gRNA-depleted libraries were purified by isopropanol precipitation.
qPCR and targeted deep sequencing
qPCR and targeted deep sequencing were performed to assess the quality of the gRNA-
depleted libraries. For qPCR, a common forward primer, annealing to the U6 promoter, and
target-specific reverse primers were used with the 2× iQ™ SYBR1 Green Supermix. A primer
pair specific to the puromycin gene in the plasmid DNA was used for internal control PCR
amplifications. One nanogram of pooled libraries was subjected to qPCR and the comparative
CT method was used to estimate specific gRNA depletion. For targeted deep sequencing, PCR
amplicons of gRNA-encoding regions were sequenced on MiniSeq or NextSeq system as
described previously[11]. Sequencing data were analyzed using count_space.py as described
previously[12].
CRISPR/Cas-based customization of pooled CRISPR libraries
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Cell culture and CRISPR library screening
HEK293T cells (ATCC CRL-11268) and HeLa cells (ATCC, CCL-2) were maintained in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin/streptomycin. HEK293T cells (5 x 106) were seeded on a 100-mm dish one
day before transfection and transfected with 15 μg of the lentiviral library and two viral pack-
aging plasmids (9 μg of psPAX2 and 6 μg of pMD2.G) using Lipofectamine 2000 according to
the manufacturer’s instructions and the culture medium was changed after 6 h. The lentiviral
particles were harvested and filtered using a 0.45-μm filter 48 h after transfection.
HeLa cells (1 x 107) were plated on a 100-mm dish and transduced with the lentivirus
(MOI ~0.1). The transduced cells were selected on media containing 1 μg/mL puromycin. For
6-TG screening, 1 μg/mL 6-TG was added to the culture medium 3 days after transduction.
After two weeks, crystal violet staining was performed to visualize 6-TG-resistant clones and
genomic DNA was isolated for analysis by targeted deep sequencing. The screening data was
analysed using the pipeline MAGeCK (ver. 0.5.6)[13].
Result and discussion
We first noted that gRNAs in the pooled CRISPR library are expressed from the U6 promoter
(originating from human or mouse) and the promoter contains the sequence 50-CCG-30
upstream of the gRNA-encoding region. Using these as PAM sequences for Cas9 proteins,
reverse-complementary gRNAs (rc-gRNAs) could be designed to target each gRNA in the
pooled CRISPR plasmid DNA library, which would eliminate specific gRNAs from the pooled
CRISPR library (Fig 1). As proof of concept, we treated Cas9 RNPs to remove HPRT1 gRNAs
from the human GeCKOv2 library[14]. Cas9 RNPs, comprising Cas9 proteins and in vitro-
transcribed rc-gRNAs targeting HPRT1 gRNAs, were treated to the GeCKOv2 plasmids DNA
library in vitro.
To confirm HPRT1 gRNA cleavage, we performed polymerase chain reaction (PCR) or
quantitative PCR (qPCR) using target-specific primers (Fig 2A). While using HPRT1-target
site-specific primer pairs, PCR was conducted successfully with wild-type GeCKOv2 libraries;
however, we could not detect PCR amplicons with the HPRT1-depleted GeCKOv2 libraries
(Fig 2B and Figure A in S1 File). We confirmed that the gRNAs were depleted dose- and time-
dependently (Figure B in S1 File). Additionally, we performed targeted deep sequencing to ver-
ify HPRT1 gRNA depletion. Among 123,411 gRNAs in total (65,383 in GeCKOv2 A library
and 58,028 in GeCKOv2 B library), only six HPRT1 gRNAs were dramatically reduced in the
HPRT1-depleted GeCKOv2 libraries (Fig 2C and 2D and S1 Table). Moreover, Cas9 RNPs
were treated with another pooled CRISPR library type, GeCKOv1 for targeted gRNA depletion
and the relative quantities of the gRNAs were analyzed by targeted deep sequencing; 1 to 7
gRNAs were confirmed to be successfully depleted from the wild type library (Figure C in S1
File and S2 Table), showing that Cas9 RNPs could selectively remove only plasmids of interest
from pooled CRISPR libraries.
We carefully considered the potential off-target effects of Cas9 RNPs in pooled CRISPR
libraries. Since all plasmid DNA in the pooled CRISPR libraries had the same PAM sequence,
we assumed that the potential off-target effect could be determined only by the mismatch tol-
erance of rc-gRNAs. Generally, pooled CRISPR libraries are designed to minimize potential
off-target effects on the genome, in order that the gRNA nucleotide sequences contained
therein are not similar[4]. Additionally, more than 3-bp mismatches between gRNA and target
sequence can be distinguished by Cas9 nucleases, which can inhibit the off-target effects[15].
We examined whether there were gRNAs with sequences similar to those of the six HPRT1
gRNAs in the GeCKOv2 libraries and in fact, there was 1 gRNA with 5-bp mismatches and 21
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gRNAs with 6-bp mismatches with the gRNAs (Table A in S1 File). The relative quantities of
the above-mentioned gRNAs in the wild-type and the HPRT1-depleted libraries did not differ
significantly from each other (Fig 2C and Table A in S1 File). These results showed that Cas9
RNPs could successfully eliminate specific gRNAs-encoding plasmids DNA from conventional
CRISPR libraries and the potential off-target effect of Cas9 RNPs were not of concern while
using well-defined pooled CRISPR libraries.
To determine whether the gRNA-depleted library could be used for functional studies, we
performed 6-thioguanine (6-TG) screening with the wild-type and the HPRT1-depleted librar-
ies. As 6-TG is cytotoxic to HPRT1-expressing cells, HPRT1 gRNAs result in positive hits in
6-TG screening because they disrupt HPRT1 and make cells resistant to 6-TG[16, 17]. Lenti-
viral particles were produced from the wild-type and the HPRT1-depleted libraries and trans-
duced into a HeLa-Cas9 stable cell line. To measure relative quantities of gRNAs in the
infected cells, genomic DNA was isolated from these cells and analyzed by targeted deep
sequencing at a depth of over 80-fold. Similar to the findings on plasmid DNA, of 123,411
gRNAs, only HPRT1 gRNAs were dramatically depleted in two independent experiments (Fig
3A and S1 Table). After confirming that the gRNAs in the cells was sufficient coverage, we
conducted recessive screening with 6-TG and observed that 6-TG-resistant clones were not
present in the cells infected with the HPRT1-depleted libraries (Fig 3B). The targeted deep
Fig 1. Schematic outline of customization of pooled CRISPR library. The gRNA-encoding plasmid DNA in the pooled CRISPR library contained the
nucleotide sequence 5’-CGG-3’, which could be used as the PAM sequence for Cas9 proteins. Cas9 RNPs, which are complexes of Cas9 proteins and rc-
gRNAs, could selectively cleave plasmid DNA possessing complementary sequences with rc-gRNA. Based on this principle, only the desired gRNAs
could be depleted from the pooled CRISPR library.
https://doi.org/10.1371/journal.pone.0199473.g001
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sequencing analysis revealed that all HPRT1 gRNAs were highly enriched in the cells infected
with the wild-type library, although not in those infected with the HPRT1-depleted library, as
in a previous study[17] (Fig 3C, Figure D in S1 File and S1 Table). Our results showed that
Cas9 RNPs could successfully eliminate gRNAs of interest in vitro and the gRNA-depleted
library could be used for high-throughput functional studies.
Scalability of our method is essential for applications in various biological research studies.
To confirm that a set of gRNAs targeting each gene could be simultaneously depleted by Cas9
RNPs, we designed rc-gRNAs for 81 gRNAs targeting 27 human kinase genes, which were
known to be the targets of FDA-approved drugs[18]. Kinases are known to be potential thera-
peutic targets and their inhibitors are used as cancer-targeting agents[19]. However, recently,
non-kinase targets of kinase inhibitors have been identified and they are gaining attention as
new therapeutic targets[20]. To construct a kinase-depleted library, 81 rc-gRNAs, which were
simultaneously transcribed in vitro, and Cas9 proteins were treated together to GeCKOv2
library A as described below in the Materials and Methods section and the quality of the
kinase-depleted library was assessed by targeted deep sequencing. The relative quantities of
gRNAs showed that all 81 gRNAs in the kinase-depleted library were dramatically reduced
compared with those in the wild-type library (Fig 4A and 4B and S3 Table). This kinase-
depleted library may be used for biomedical screening to identify new druggable target genes.
Taken together, we show that Cas9 RNPs, comprising Cas9 proteins and in vitro transcribed
rc-gRNAs, could simultaneously deplete multiple gRNAs from conventional CRISPR libraries
Fig 2. Cas9 RNPs treatment for the HPRT1-depleted CRISPR library generation. (A) Schematic outline of PCR to assess the quality of the gRNA-
depleted library. The forward primer annealed to the U6 promoter and the reverse primers could selectively anneal to the target sequences. While using
the primer pairs, amplification occurred in the wild-type library, although not in the gRNA-depleted library. (B) The PCR amplicons of the HPRT1-
depleted GeCKOv2 library were analyzed by agarose gel electrophoresis. Each of the GeCKOv2 A and B libraries had three HPRT1 gRNAs, all of which
were depleted from each library. For all six reverse primers annealed to the HPRT1 gRNA-encoding plasmid DNA, amplification occurred with the
wild-type libraries as templates, although not with the HPRT1-depleted libraries. A pair of primers annealing to puromycin-encoding sequences in the
plasmid DNA was used for internal control amplification. The primer sequences are listed in Table B in S1 File (C) Targeted deep sequencing analysis
of the HPRT1-depleted libraries as described previously[11]. Scatter plots of the HPRT1-depleted GeCKOv2 A (left) and the HPRT1-depleted GeCKOv2
B (right) libraries showed that only HPRT1 gRNAs were depleted from the wild-type GeCKOv2 libraries. (D) Relative HPRT1 gRNA quantities were
calculated from the targeted deep sequencing data. Numerical data are presented in S1 Table.
https://doi.org/10.1371/journal.pone.0199473.g002
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without off-target effects and the gRNA-depleted libraries could be used for high-throughput
screening.
We developed a CRISPR/Cas9 based method for customizing conventional pooled libraries.
Although previous studies show that Cas9 RNP can be used for eliminating unwanted DNAs
such as mitochondrial rRNA in RNA-Seq libraries[21, 22], we first showed that Cas9 RNPs
could deplete only gRNAs of interest and multiple gRNAs could simultaneously be eliminated
in pooled CRISPR libraries. The advantage of our method over the generation of new libraries
is its ability to reduce the time to construct a pooled library (Figure E in S1 File). Furthermore,
we presume this method can reduce cost and labour while removing up to 100 gRNAs
(Figure F in S1 File). Interestingly, the deep sequencing results showed HPRT1 gRNAs
remained in the HPRT1-depleted library at low frequencies, but the HPRT1 gRNAs were not
enriched after 6-TG screenings using the HPRT1-depleted library. Based on these results, it
appeared that the HPRT1 gRNAs, interpreted as remaining in the HPRT1-depleted libraries,
were either due to deep sequencing errors or did not exceed the threshold that could affect
library screening.
Fig 3. High-throughput screening with the HPRT1-depleted libraries. (A) Relative HPRT1 gRNA quantities were calculated from the targeted deep
sequencing data on the cells infected with each library. Error bars indicate SEM. P< 0.01, P< 0.001. Student’s t-test. (B) Crystal violet staining
images after 6-TG selection of cells infected with designated libraries. 6-TG-resistant clones were observed only in the cells infected with the wild-type
libraries. (C) Log2-fold change in gRNAs in cells infected with the wild-type or the HPRT1-depleted GeCKOv2 A library after 6-TG selection. All three
HPRT1 gRNAs were highly enriched in the cells infected with the wild-type library. Numerical data are presented in S1 Table.
https://doi.org/10.1371/journal.pone.0199473.g003
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Our method can be applied to genetic screening in diverse ways, for example, to exclude
positive genes or gene sets in recessive screening for reducing the number of genetic screening
rounds required to identify unknown target genes. Other types of Cas proteins which have dif-
ferent types of PAM sequences, such as Cpf1 with the T-rich PAM sequences, can be adopted
to extend the usefulness of the method. Furthermore, this method is applicable to other library
types, such as shRNA and cDNA libraries, with the potential to expand the availability of vari-
ous pooled libraries in biomedical research.
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S1 File. Supplementary figures and tables.
(DOCX)
S1 Table. Deep sequencing results of the HPRT1-depleted library.
(XLSX)
S2 Table. Deep sequencing results of the gRNA-depleted library (GeCKOv1).
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S3 Table. Deep sequencing results of the 27 kinases-depleted library.
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Fig 4. Cas9 RNPs treatment for depletion of multiple gRNAs. (A) Targeted deep sequencing analysis of the kinase-depleted GeCKOv2 A library. The
scatter plots showed that all 81 gRNAs that targeted 27 human kinase genes were depleted in the kinase-depleted compared with the wild-type library.
(B) Relative gRNA quantities were calculated from the deep sequencing data. Numerical data are presented in S3 Table.
https://doi.org/10.1371/journal.pone.0199473.g004
CRISPR/Cas-based customization of pooled CRISPR libraries
PLOS ONE | https://doi.org/10.1371/journal.pone.0199473 June 20, 2018 7 / 9
Acknowledgments
We are grateful to Heon Seok Kim and members of our laboratory for the helpful discussion
of this study.
Author Contributions
Conceptualization: Yongsub Kim.
Data curation: An-Hee Jang, Yongsub Kim.
Funding acquisition: Jiyeon Kweon, Yongsub Kim.
Investigation: Jiyeon Kweon, Da-eun Kim.
Methodology: Da-eun Kim, An-Hee Jang.
Supervision: Yongsub Kim.
Validation: Jiyeon Kweon, An-Hee Jang.
Visualization: Da-eun Kim.
Writing – original draft: Jiyeon Kweon, Da-eun Kim, Yongsub Kim.
References
1. Boehm JS, Hahn WC. Towards systematic functional characterization of cancer genomes. Nat Rev
Genet. 2011; 12(7):487–98. https://doi.org/10.1038/nrg3013 PMID: 21681210.
2. Kim H, Kim JS. A guide to genome engineering with programmable nucleases. Nat Rev Genet. 2014;
15(5):321–34. https://doi.org/10.1038/nrg3686 PMID: 24690881.
3. Shalem O, Sanjana NE, Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev
Genet. 2015; 16(5):299–311. https://doi.org/10.1038/nrg3899 PMID: 25854182.
4. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, et al. Genome-scale CRISPR-Cas9
knockout screening in human cells. Science. 2014; 343(6166):84–7. https://doi.org/10.1126/science.
1247005 PMID: 24336571.
5. Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 sys-
tem. Science. 2014; 343(6166):80–4. https://doi.org/10.1126/science.1246981 PMID: 24336569.
6. Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, et al. Genome-scale
transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015; 517(7536):583–8.
https://doi.org/10.1038/nature14136 PMID: 25494202.
7. Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, et al. Genome-Scale
CRISPR-Mediated Control of Gene Repression and Activation. Cell. 2014; 159(3):647–61. https://doi.
org/10.1016/j.cell.2014.09.029 PMID: 25307932.
8. Klann TS, Black JB, Chellappan M, Safi A, Song L, Hilton IB, et al. CRISPR-Cas9 epigenome editing
enables high-throughput screening for functional regulatory elements in the human genome. Nat Bio-
technol. 2017; 35(6):561–8. https://doi.org/10.1038/nbt.3853 PMID: 28369033.
9. Hess GT, Fresard L, Han K, Lee CH, Li A, Cimprich KA, et al. Directed evolution using dCas9-targeted
somatic hypermutation in mammalian cells. Nat Methods. 2016; 13(12):1036–42. https://doi.org/10.
1038/nmeth.4038 PMID: 27798611.
10. Kurata M, Rathe SK, Bailey NJ, Aumann NK, Jones JM, Veldhuijzen GW, et al. Using genome-wide
CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in
AML. Sci Rep. 2016; 6:36199. https://doi.org/10.1038/srep36199 PMID: 27808171 NeoClone Biotech-
nology, Inc., B-MoGen Biotechnologies Inc., Recombinetics Inc. and Discovery Genomics, Inc. No
resources or personnel from either company were involved in this research in any way. The remaining
authors declare no competing financial interest.
11. Kweon J, Jang AH, Kim DE, Yang JW, Yoon M, Rim Shin H, et al. Fusion guide RNAs for orthogonal
gene manipulation with Cas9 and Cpf1. Nat Commun. 2017; 8(1):1723. https://doi.org/10.1038/
s41467-017-01650-w PMID: 29167440.
12. Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, et al. Genome-scale
CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 2017; 12(4):828–63.
https://doi.org/10.1038/nprot.2017.016 PMID: 28333914.
CRISPR/Cas-based customization of pooled CRISPR libraries
PLOS ONE | https://doi.org/10.1371/journal.pone.0199473 June 20, 2018 8 / 9
13. Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential
genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 2014; 15(12):554. https://
doi.org/10.1186/s13059-014-0554-4 PMID: 25476604.
14. Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening.
Nat Methods. 2014; 11(8):783–4. https://doi.org/10.1038/nmeth.3047 PMID: 25075903.
15. Cho SW, Kim S, Kim Y, Kweon J, Kim HS, Bae S, et al. Analysis of off-target effects of CRISPR/Cas-
derived RNA-guided endonucleases and nickases. Genome Res. 2014; 24(1):132–41. https://doi.org/
10.1101/gr.162339.113 PMID: 24253446.
16. Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera Mdel C, Yusa K. Genome-wide recessive genetic screen-
ing in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol. 2014; 32(3):267–73.
https://doi.org/10.1038/nbt.2800 PMID: 24535568.
17. Kim HS, Lee K, Bae S, Park J, Lee CK, Kim M, et al. CRISPR/Cas9-mediated gene knockout screens
and target identification via whole-genome sequencing uncover host genes required for picornavirus
infection. J Biol Chem. 2017; 292(25):10664–71. https://doi.org/10.1074/jbc.M117.782425 PMID:
28446605.
18. Xu J, Wang P, Yang H, Zhou J, Li Y, Li X, et al. Comparison of FDA Approved Kinase Targets to Clinical
Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks. Biomed Res Int.
2016; 2016:2509385. https://doi.org/10.1155/2016/2509385 PMID: 27547755.
19. Wu P, Nielsen TE, Clausen MH. FDA-approved small-molecule kinase inhibitors. Trends Pharmacol
Sci. 2015; 36(7):422–39. https://doi.org/10.1016/j.tips.2015.04.005 PMID: 25975227.
20. Munoz L. Non-kinase targets of protein kinase inhibitors. Nat Rev Drug Discov. 2017; 16(6):424–40.
https://doi.org/10.1038/nrd.2016.266 PMID: 28280261.
21. Gu W, Crawford ED, O’Donovan BD, Wilson MR, Chow ED, Retallack H, et al. Depletion of Abundant
Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in
sequencing libraries and molecular counting applications. Genome Biol. 2016; 17:41. https://doi.org/10.
1186/s13059-016-0904-5 PMID: 26944702.
22. Wu J, Huang B, Chen H, Yin Q, Liu Y, Xiang Y, et al. The landscape of accessible chromatin in mamma-
lian preimplantation embryos. Nature. 2016; 534(7609):652–7. https://doi.org/10.1038/nature18606
PMID: 27309802.
CRISPR/Cas-based customization of pooled CRISPR libraries
PLOS ONE | https://doi.org/10.1371/journal.pone.0199473 June 20, 2018 9 / 9
